Head-to-head · WeighScore
HealthRX vs NuvaHealth
The verdict
HealthRX takes it — 86.1/100 to 74.2/100.
HealthRX grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A LegitScript-certified (#50087439) physician-supervised program that runs a rare oral GLP tablet alongside the usual injectables — compounded semaglutide from ~$189/mo, tirzepatide/GLP+GIP up to ~$349, with a brand Ozempic pass-through if you need it.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | HealthRX | NuvaHealth |
|---|---|---|
| WeighScore | 86.1/100 | 74.2/100 |
| Grade | B | C |
| Scorecard rank | #8 | #65 |
| Semaglutide | $189/mo | $139/mo (first-month rate, compounded) |
| Tirzepatide | $349/mo | $229/mo (first-month rate, compounded) |
| Coverage | Not publicly listed | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Graded #8 · B
Strengths
- LegitScript-certified (#50087439) — a genuine, verifiable trust signal
- Physician-supervised intake with licensed providers
- Both molecules plus a rare oral GLP tablet option
- Transparent flat monthly pricing, no insurance required
Where it loses points
- Compounded semaglutide/tirzepatide is not FDA-approved
- Some tiers are company-stated and the public site is thin
- Brand Ozempic is a steep pass-through (~$1,299)
- State count is not publicly listed
Graded #65 · C
Strengths
- LegitScript Certified seal displayed on the marketing site (the standard third-party telehealth/pharmacy accreditation)
- Free and fast delivery + 24/7 patient support disclosed on the home page
- Newark, DE address suggests a US-incorporated entity (vs offshore)
- $139 first-month price for compounded semaglutide injection is among the cheapest in the US compounded telehealth market
- $229 first-month price for compounded tirzepatide injection sits in the lower-median range
Where it loses points
- Standard ongoing monthly price NOT publicly disclosed (gated behind checkout) — patients should ask for the maintenance-dose price before committing
- Specific legal entity name + state of incorporation NOT publicly disclosed on the home page — material YMYL transparency gap
- Pharmacy partners NOT publicly named — material YMYL transparency gap
- Per-state availability NOT enumerated; verify your state ships before purchase
- Lab work + coaching support NOT publicly disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.